By Nathan Dukes
HCL Axon has won a five year global IT contract with international pharmaceuticals giant GlaxoSmithKline (GSK).
The agreement, called the Global Strategic Information Technology Master Services Agreement, details that HCL AXON and HCL Technologies will provide systems integration, SAP implementation and IT consulting services to GSK globally.
Under the agreement, HCL will first act as GSK’s systems integration partner for a large SAP-enabled business transformation programme. The scope of the project is currently in development.
Steve Cardell, President, HCL AXON, said GSK’s major global SAP transformation project is a great win for HCL, following their acquisition of UK based IT company AXON in December 2008.
“It keeps our strategy of becoming the largest global SAP-based business transformation provider firmly on track and confirms the rationale behind the merger with HCL,” he said.
HCL win join fellow Indian outsourcing counterpart Satyam at GSK, who won the global support contract for the pharmaceuticals company earlier this year.
HCL have confirmed their will be no change to the existing support contract with Satyam, and confirmed their roles will remain separated.
David Mitchell, SVP, IT Research at analyst firm Ovum, said “SAP continues to be a strategic application choice for many companies seeking to transform their business through an enterprise technology and services platform”.
“Ensuring that such transformation programmes deliver true value needs a technology partner who understands the technology in-depth but who also truly understands business. HCL, amplified by their Axon acquisition, has a good blend of technology and business expertise to support GSK through the years ahead,” Mitchell continued
The win further accelerates HCL’s rapid growth in the life science industry, one HCL says is one of its fastest growing industry verticals.
GSK owns several health and pharmaceutical brands in Australia, including Ribena, Macleans, Nicabate, Panadol and Zantac.